1957 & Co(08495.HK)独立非执董被联交所谴责
1957 & Co(08495.HK)公布,独立非执行董事吴伟雄被联交所谴责,不过其并无参与公司日常营运。经考虑他将参加联交所指示的有关监管及法律主题(包括上市规则合规)的24小时培训,并无被取消担任上市公司董事的资格。
除上述纪律处分外,吴伟雄并无其他不良董事履职纪录,而经进一步考虑背景、专业知识、技能、经验及独立性,董事会认为,待根据联交所的指示完成培训後,其仍适合担任独立非执行董事兼公司审核委员会及提名委员会成员。
吴伟雄因任德普科技(前股份代号3823)独立非执行董事,违反上市规则,原因为其未能采取足够措施或实施有效的风险管理及内部监控程序以监察德普於内地合营企业的营运。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.